Search results
Results From The WOW.Com Content Network
The number of people who are physically restrained in Japanese psychiatric hospitals continues to increase. In 2014 more than 10,000 people were restrained-the highest ever recorded, and more than double the number a decade earlier. [25] It is thought that some of that increase includes older patients with dementia.
Geriatrics, or geriatric medicine, [1] is a medical specialty focused on providing care for the unique health needs of the elderly. [2] The term geriatrics originates from the Greek γέρων geron meaning "old man", and ιατρός iatros meaning "healer". It aims to promote health by preventing, diagnosing and treating disease in older ...
Psychological therapies which are considered as potential treatments for dementia include music therapy, [5] reminiscence therapy, [6] cognitive reframing for caretakers, [7] validation therapy, [8] and mental exercise. [9] Interventions may be used in conjunction with pharmaceutical treatment and can be classified within behavior, emotion ...
The Liverpool Care Pathway for the Dying Patient ( LCP) was a care pathway in the United Kingdom (excluding Wales) covering palliative care options for patients in the final days or hours of life. It was developed to help doctors and nurses provide quality end-of-life care, to transfer quality end-of-life care from the hospice to hospital setting.
But taking care of a loved one with dementia can be particularly challenging. There are 16.7 million people who care for folks with dementia, according to the Alzheimer’s Association. They often ...
A Posey vest is a type of medical restraint used to restrain a patient to a bed or chair. [1] Its name comes from the J.T. Posey Company, its inventor, though the term "Posey" is used generically to describe all such devices. [2] The vest is placed on the patient, and meshy straps extending from each corner are tied either individually to each ...
Posterior cortical atrophy ( PCA ), also called Benson's syndrome, is a rare form of dementia which is considered a visual variant or an atypical variant of Alzheimer's disease (AD). [1] [2] [3] The disease causes atrophy of the posterior part of the cerebral cortex, resulting in the progressive disruption of complex visual processing. [4]
Doctors and researchers should only use blood tests proven to have a greater than 90% accuracy rate, said Alzheimer’s Association chief science officer Maria Carrillo.